Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07460752) titled 'Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients' on March 4.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Mayo Clinic

Condition: Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Locally Advanced Hormone Receptor-Positive Breast Carcinoma

Intervention: Procedure: Biospe...